WHO Collaborating Centres
Global database
Version 1.5
Search / List / Details
Ref.No. [Initiator]
CHN-19 [Headquarters]
Status
Active
Title of the centre:
  WHO Collaborating Centre for Drug Quality Assurance

Director / Head: 
  Dr Bo Li
 




Institution:
 
  National Institute for Food and Drug Control
Address:
  No. 2 Tiantan Xili
  100050
 
Town:
  Beijing
Country:
  CHINA
Region:
  WPRO
Phone:
  (86-10) 6709 5790
Fax:
  (86-10) 6701 4758
Date of Designation:
  26/Sep/1980
Last Redesignation:
  26/May/2016
Expiry:
  26/May/2020
Terms of Reference:
  1. To collaborate in the development and revision of pharmacopoeia monographs on the active pharmaceutical ingredients (API) and finished pharmaceutical products (FPP), including the collaborative study of international chemical references substance (ICRS). 
  2. To coordinate the establishment of references substance for pharmaceuticals. 
  3. To collaborate with WHO in the assurance of medicines quality, development of analytical methods and post-marketing monitoring of medicines quality (including suspected SSFFC medical products). 
  4. To carry out the training of the technical staff/personnel, especially from developing countries, on the technologies of medicine analysis. 
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
Subjects:
  1. Pharmaceuticals (including essential drugs and medicines) 
  2.  
  3.  
Types of activity:
  1. Provision of reference substances and other services 
  2. Product development (guidelines; manual; methodologies; etc.) 
  3.  
WHO Outputs:
  Ower: 11.1 - Formulation and monitoring of comprehensive national policies on access, quality and use of essential medical products and technologies advocated and supported.
  Ower: 11.2 - International norms, standards and guidelines for the quality, safety, efficacy and cost effective use of medical products and technologies developed and their national and/or regional implementation advocated and supported.
  Ower: 11.3 - Evidence based policy guidance on promoting scientifically sound and cost-effective use of medical products and technologies by health workers and consumers developed and supported within the Secretariat and regional and national programmes.
Responsible Officer:
  KOPP Sabine
Phone:
  +41 22 791 3636
Email:
  kopps@who.int

Technical Counterpart:
  KIM Uhjin
Phone:
  +63 2 5289028
Email:
  kimu@who.int
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
  Link to eWork